Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

BACKGROUND AND AIM: Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cirrhosis (PBC), but not all cases respond well. Evidence has shown that combination therapy of UDCA with bezafibrate significantly improved liver function. A meta-analysis was performed to assess the effic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Drug Des Devel Ther
Huvudupphovsmän: Yin, Qin, Li, Jingjing, Xia, Yujing, Zhang, Rong, Wang, Jianrong, Lu, Wenxia, Zhou, Yuqing, Zheng, Yuanyuan, Abudumijiti, Huerxidan, Chen, Rongxia, Chen, Kan, Li, Sainan, Liu, Tong, Wang, Fan, Lu, Jie, Zhou, Yingqun, Guo, Chuanyong
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599574/
https://ncbi.nlm.nih.gov/pubmed/26491252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92041
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk